Hong Kong Pharma Digital Technology Holdings Limited (HKPD) Income Statement
HKPD FY2026 at a glance
Fiscal year ended March 31, 2026 · U.S. dollarsHKPD revenue and net income
Where HKPD's revenue goes
FY2026Each bar shows an amount and its share of revenue. HKPD kept −8.5% of revenue as net income.
HKPD profit margins
HKPD growth rates
to FY2026| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −33.9% | +2.3% | — | — |
| Gross profit | −42.6% | −20.3% | — | — |
| Operating income | −853.5% | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
HKPD quarterly EPS vs estimates
Hong Kong Pharma Digital Technology beat the analyst EPS estimate in 1 of the last 2 quarters.
HKPD income statement
| FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Revenue | $13.4M | $20.3M | $16.7M | $12.6M |
| Cost of revenue | $12.0M | $17.9M | $13.1M | $9.8M |
| Gross profit | $1.4M | $2.4M | $3.6M | $2.7M |
| Sales, general & admin | $2.4M | $2.2M | $1.9M | $1.8M |
| Total operating expenses | $2.4M | $2.3M | $2.0M | $1.7M |
| Operating income | −$994,902 | $132,038 | $1.6M | $1.0M |
| Interest income | $454 | $1,741 | $474 | $219 |
| Interest expense | $133,395 | $97,667 | $82,766 | $23,242 |
| Income before taxes | −$1.1M | $36,112 | $1.5M | $1.0M |
| Income taxes | $7,666 | $63,168 | $196,252 | $22,574 |
| Net income | −$1.1M | −$27,056 | $1.3M | $998,196 |
| EBITDA | −$317,792 | $1.2M | $2.5M | $1.8M |
| EPS (diluted) | −$0.03 | $0.00 | $0.13 | $0.15 |
| Gross margin | 10.3% | 11.9% | 21.3% | 21.8% |
| Operating margin | −7.4% | 0.6% | 9.6% | 8.3% |
| Net margin | −8.5% | −0.1% | 8.0% | 7.9% |
| Jun '26 | Dec '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.3M | $7.1M | $4.6M | $9.2M | $4.6M | $11.1M | $5.5M | $9.7M | $4.8M | $7.0M |
| Cost of revenue | $5.8M | $6.2M | $4.4M | $8.7M | $4.4M | $9.2M | $4.6M | $7.5M | $3.7M | $5.7M |
| Gross profit | $455,545 | $930,764 | $254,778 | $509,556 | $254,778 | $1.9M | $952,802 | $2.2M | $1.1M | $1.3M |
| Total operating expenses | $1.7M | $696,445 | $702,277 | $1.4M | $702,277 | $878,568 | $439,284 | $923,234 | $461,617 | $1.0M |
| Operating income | −$1.2M | $234,319 | −$447,500 | −$895,000 | −$447,500 | $1.0M | $513,518 | $1.3M | $649,721 | $308,820 |
| Interest expense | $70,878 | $62,517 | — | $47,750 | — | $48,176 | — | $47,636 | — | $34,656 |
| Income before taxes | −$1.3M | $171,802 | −$471,375 | −$942,750 | −$471,375 | $978,862 | $489,431 | $1.3M | $625,903 | $274,164 |
| Income taxes | −$10,401 | $18,067 | $43,568 | $87,136 | $43,568 | $150,304 | $75,152 | $171,124 | $85,562 | $25,126 |
| Net income | −$1.3M | $153,735 | −$427,808 | −$855,616 | −$427,808 | $828,560 | $414,280 | $1.1M | $540,340 | $249,036 |
| EBITDA | −$988,909 | $258,845 | −$396,662 | −$203,605 | −$396,662 | $1.5M | $529,670 | $1.4M | $680,949 | $371,062 |
| EPS (diluted) | — | — | −$0.08 | — | $0.08 | — | — | — | — | — |
| Gross margin | 7.2% | 13.0% | 5.5% | 5.5% | 5.5% | 17.2% | 17.2% | 23.0% | 23.0% | 19.1% |
| Operating margin | −19.5% | 3.3% | −9.7% | −9.7% | −9.7% | 9.3% | 9.3% | 13.4% | 13.4% | 4.4% |
| Net margin | −20.5% | 2.2% | −9.3% | −9.3% | −9.3% | 7.5% | 7.5% | 11.2% | 11.2% | 3.6% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in HKPD's financial statements (latest annual report filed August 7, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
HKPD financial results
In fiscal year 2026 (ended March 31, 2026), Hong Kong Pharma Digital Technology reported revenue of $13.4 million, down 33.9% from the year before. It had a net loss of $1.1 million, a net profit margin of −8.5%. Diluted earnings per share came to −$0.03.
See the HKPD stock overview for the latest quote and news, or the HKPD chart for price history and technical indicators.
HKPD income statement FAQ
What is Hong Kong Pharma Digital Technology's annual revenue?
Hong Kong Pharma Digital Technology reported total revenue of $13.4 million for fiscal year 2026, which ended on March 31, 2026. That was down 33.9% from $20.3 million the previous year.
Is Hong Kong Pharma Digital Technology profitable?
No. Hong Kong Pharma Digital Technology reported a net loss of $1.1 million in fiscal 2026, a net profit margin of −8.5%; its operating margin was −7.4%.
What is Hong Kong Pharma Digital Technology's gross margin?
Hong Kong Pharma Digital Technology's gross margin was 10.3% in fiscal 2026: for every $100 of revenue, Hong Kong Pharma Digital Technology kept $10 after the direct cost of its products and services.
What are Hong Kong Pharma Digital Technology's earnings per share?
Hong Kong Pharma Digital Technology earned $-0.03 per diluted share in fiscal 2026, compared with $-0.00 a year earlier.
When does Hong Kong Pharma Digital Technology's fiscal year end?
Hong Kong Pharma Digital Technology's fiscal year ends in March. The latest annual report covers the year ended March 31, 2026 and was filed on August 7, 2026.